Louis J. Arcudi III

Chief Executive Officer

Louis Arcudi became Chief Executive Officer in February 2021. Mr. Arcudi brings more than 20 years of financial, strategic, and operational experience to Millendo. Until recently, he served as the Chief Financial Officer of Millendo starting in November of 2018. Prior to joining Millendo he served as Senior Vice President of Operations and Chief Financial Officer at Idera Pharmaceuticals. Prior to Idera, he served as Vice President of Finance and Administration for Peptimmune, Inc. where he handled all financial business and operations. Before his time at Peptimmune, Mr. Arcudi served as Senior Director of Finance and Administration at Genzyme Molecular Oncology Corporation, after serving as Director of International Finance and Commercial Operations at Genzyme Corporation. Earlier in his career, he held finance positions with increasing levels of responsibility at Cognex Corporation, Millipore Corporation and General Motors Corporation.

Mr. Arcudi obtained an MBA from Bryant College and a B.S. in accounting and information systems from the University of Southern New Hampshire.


US Offices

Corporate Headquarters

110 Miller Avenue, Suite 100
Ann Arbor, MI 48104

Europe Office

Lyon Office

Millendo Therapeutics SAS
c/o Canopee consulting
8 rue Berjon
69009 Lyon
Tel +33 472 18 94 28

Lexington Office

420 Bedford Street,
Suite 260
Lexington, MA 02420

Scroll to Top